Mortgage Protection booklet - Irish Life
Mortgage Protection booklet - Irish Life
Mortgage Protection booklet - Irish Life
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
3. Aplastic anaemia - of specified severity<br />
Plan definition:<br />
A definite diagnosis by a Consultant Haematologist of permanent<br />
bone marrow failure which results in anaemia, neutropenia and<br />
thrombocytopenia requiring treatment with at least one of the following:<br />
• Blood transfusion<br />
• Marrow stimulating agents<br />
• Immunosuppressive agents<br />
• Bone marrow transplant<br />
For the above definition, the following are not covered:<br />
• All other types of anaemia<br />
In simpler terms:<br />
Aplastic anaemia is a failure of the bone marrow to produce sufficient<br />
blood cells for the circulation. When this function of the marrow<br />
declines, the main blood constituents (red cells, white cells, platelets)<br />
decline or cease production and the individual becomes progressively<br />
more dependent on blood transfusions.<br />
You can claim if a Consultant Haematologist diagnoses permanent bone<br />
marrow failure which is treated by blood transfusion, agents to stimulate<br />
the bone marrow, immunosuppressive agents or a bone marrow<br />
transplant.<br />
26<br />
4. Bacterial Meningitis – resulting in<br />
permanent symptoms<br />
Plan definition:<br />
A definite diagnosis of Bacterial Meningitis causing inflammation of<br />
the membranes of the brain or spinal cord resulting in permanent<br />
neurological deficit with persisting clinical symptoms*. The diagnosis<br />
must be confirmed by a Consultant Neurologist.<br />
For the above definition, the following are not covered:<br />
• All other forms of meningitis including viral meningitis.<br />
(Adult and Child cover)<br />
*”permanent neurological deficit with persisting clinical symptoms” is<br />
defined as:<br />
Symptoms of dysfunction in the nervous system that are present<br />
on clinical examination and expected to last throughout the insured<br />
person’s life.<br />
Symptoms that are covered include numbness, hyperaesthesia<br />
(increased sensitivity), paralysis, localised weakness, dysarthria (difficulty<br />
with speech), aphasia (inability to speak), dysphagia (difficulty in<br />
swallowing), visual impairment, difficulty in walking, lack of coordination,<br />
tremor, seizures, dementia, delirium and coma.